<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126395">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01456949</url>
  </required_header>
  <id_info>
    <org_study_id>STOP AF PAS</org_study_id>
    <nct_id>NCT01456949</nct_id>
  </id_info>
  <brief_title>Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)</brief_title>
  <acronym>STOP AF PAS</acronym>
  <official_title>Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Atrial Fibrillation Solutions</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Atrial Fibrillation Solutions</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Post-Approval Study (PAS) is a prospective multi-center, non-randomized, single arm,
      controlled,unblinded clinical study designed to provide long-term safety and effectiveness
      of the Arctic Front® Cardiac CryoAblation System.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Safety and effectiveness will be evaluated against pre-specified performance criteria as
      determined by the sponsor and FDA. The criteria set in this study have been previously used
      to demonstrate safety and effectiveness in cryoablation and radio-frequency ablation for the
      treatment of paroxysmal atrial fibrillation.

      The analyses of the primary effectiveness objective will take place once all the subjects
      with a study cryoablation procedure attempt have reached 36 months of follow-up
      post-cryoablation procedure. The analysis of the primary safety objective will take place
      once all the subjects with a study cryoablation procedure attempt have reached 12 months of
      follow-up post-cryoablation procedure. The analyses for the secondary objectives will take
      place once all subjects with a study cryoablation attempt have reached 36 months of
      follow-up post-cryoablation procedure.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness</measure>
    <time_frame>Through 36 months</time_frame>
    <description>Evaluated by assessing the rate of subjects free of chronic treatment failure with paroxysmal atrial fibrillation who have failed one or more Atrial Fibrillation Drugs (AFDs).
Chronic treatment failure is defined as:
Documented atrial fibrillation lasting longer than 30 seconds (outside the 90 day blanking period) OR
Intervention for atrial fibrillation (except for repeat cryoablation during the 90 day blanking period)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>12 Months</time_frame>
    <description>Demonstrate safety (through 12 months) of Arctic Front® Cardiac CryoAblation Catheter System, including the Freezor® MAX Cardiac Cryoablation Catheter by assessing the rate of subjects experiencing Cryoablation Procedure Events (CPEs) with paroxysmal atrial fibrillation who have failed one or more Atrial Fibrillation Drugs (AFDs).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chronic Safety</measure>
    <time_frame>Annually, through 3 years</time_frame>
    <description>Freedom from Major Atrial Fibrillation Event (MAFE): A MAFE is a serious adverse event (SAE) which has not been categorized as a cryoablation procedure event.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic Effectiveness</measure>
    <time_frame>Annually, through 3 years</time_frame>
    <description>Freedom from chronic treatment failure, defined as:
Documented atrial fibrillation lasting longer than 30 seconds (outside the 90 day blanking period) OR
Intervention for atrial fibrillation (except for repeat cryoablation during the 90 day blanking period)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Paroxysmal Atrial Fibrillation (PAF)</condition>
  <arm_group>
    <arm_group_label>Single Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic Arctic Front® Cardiac CryoAblation System</intervention_name>
    <description>Cardiac cryoablation to isolate the pulmonary veins using the Arctic Front® CryoAblation System, with point ablation using the Freezor® Max as needed.</description>
    <arm_group_label>Single Arm</arm_group_label>
    <other_name>Medtronic CryoCath CryoConsole</other_name>
    <other_name>Arctic Front® Cardiac CryoAblation Catheter</other_name>
    <other_name>Arctic Front Advance™ Cardiac CryoAblation Catheter</other_name>
    <other_name>Freezor® MAX Cardiac CryoAblation Catheter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Documented PAF:

               -  Diagnosis of paroxysmal atrial fibrillation (PAF), AND

               -  2 or more episodes of AF during the 3 months preceding the consent Date, AND

               -  At least 1 episode of AF documented with a tracing within 12 months preceding
                  the consent date.

          2. Age 18 years or older

          3. Failure for the treatment of AF (effectiveness or intolerance) of at least one
             membrane active AAD for rhythm control.

        Exclusion Criteria:

          1. Any previous left atrial (LA) ablation (except permissible retreatment subjects)

          2. Any previous LA surgery

          3. Current intracardiac thrombus (can be treated after thrombus is resolved)

          4. Presence of any pulmonary vein stents

          5. Presence of any pre-existing pulmonary vein stenosis

          6. Pre-existing hemidiaphragmatic paralysis

          7. Anteroposterior LA diameter &gt; 5.5 cm by TTE

          8. Presence of any cardiac valve prosthesis

          9. Clinically significant mitral valve regurgitation or stenosis

         10. Myocardial infarction, PCI / PTCA or coronary artery stenting which occurred during
             the 3 month interval preceding the Consent Date

         11. Unstable angina

         12. Any cardiac surgery which occurred during the 3 month interval preceding the Consent
             Date

         13. Any significant congenital heart defect corrected or not (including atrial septal
             defects or pulmonary vein abnormalities but not including minor PFO)

         14. NYHA class III or IV congestive heart failure

         15. Left ventricular ejection fraction (LVEF) &lt; 40%

         16. 2º (Type II) or 3º atrioventricular block

         17. Presence of a permanent pacemaker, biventricular pacemaker, atrial defibrillator or
             any type of implantable cardiac defibrillator (with or without biventricular pacing
             function)

         18. Brugada syndrome

         19. Long QT syndrome

         20. Arrhythmogenic right ventricular dysplasia

         21. Sarcoidosis

         22. Hypertrophic cardiomyopathy

         23. Known cryoglobulinemia

         24. Uncontrolled hyperthyroidism

         25. Any cerebral ischemic event (strokes or TIAs) which occurred during the 6 month
             interval preceding the Consent Date.

         26. Any woman known to be pregnant

         27. Life expectancy less than one (1) year

         28. Current or anticipated participation in any other clinical trial of a drug, device or
             biologic during the duration of this study not pre-approved by Medtronic

         29. Unwilling or unable to comply fully with study procedures and followup
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bradley P. Knight, MD, FACC, FHRS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern Memorial Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alaska Heart Institute</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Banner Good Samaritan Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Colorado Heart and Vascular</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Daytona Heart Group</name>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <zip>32114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Broward General Medical Center</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33316</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>WellStar Kennestone Hospital</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Advanced Cardiovascular Institute</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metropolitan Cardiology Consultants PA</name>
      <address>
        <city>Coon Rapids</city>
        <state>Minnesota</state>
        <zip>55433</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital - Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HealthEast St. Joseph's Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bryan LGH</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asheville Cardiology Associate PA</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bethesda North Hospital l TriHealth Hatton Institute</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart Institute</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capital Cardiovascular Associates</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Doylestown Cardiology Associates</name>
      <address>
        <city>Doylestown</city>
        <state>Pennsylvania</state>
        <zip>18901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lancaster Heart &amp; Stroke</name>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <zip>17602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia Heart Clinic</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stern Cardiovascular</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Thomas Research Institute</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Episcopal Hospital - Texas Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Research Institute</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22031</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Victoria Cardiac Arrhythmia Trials Inc</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital du Sacre Coeur de Montreal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McGill University Health Centre</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire de Cardiologie et de Pneumologie de Québec</name>
      <address>
        <city>Quebec</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 20, 2016</lastchanged_date>
  <firstreceived_date>October 19, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial fibrillation (AF)</keyword>
  <keyword>Paroxysmal atrial fibrillation (PAF)</keyword>
  <keyword>Arrythmias</keyword>
  <keyword>Cardiac Arrythmias</keyword>
  <keyword>Cardiac ablation</keyword>
  <keyword>Cryoablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
